论文部分内容阅读
Aim: JD-30 is an active fraction extracted from Danggui-Shaoyao-San under guidance of bioactive evaluation in our previous studies.It has been reported that JD-30 could ameliorate cognition disorders and improve synaptic plasticity reduction in several Alzheimers disease (AD) animal models.